- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03602794
A Comparison of Local Infiltration Analgesia and Pecs Block for Analgesia in Mastectomy With Axillary Dissection - an Equivalence Study
Study Overview
Status
Intervention / Treatment
Detailed Description
Total breast removal with armpit dissection may be a painful surgery. Pectoral nerve block (Pecs block) is common pain relief method used to reduce pain after breast surgery.
The Pecs block is a pain relief method technique at targeted body part. The Pecs block numbs nerves which supply sensation to the upper chest wall, armpit and upper arm. This procedure is only possible under ultrasound guidance and is carried out by the anaesthetist (medical specialist who administers anaesthetics) after patients are put under general anaesthesia.
Despite the advantages of Pecs block in pain management, this method is not always available to all patients due to various reasons. These reasons include the availability of ultrasound machine to facilitate the method, presence of anaesthetist to carry out the procedure and additional time required to perform this method in the operating theatre.
Another method has been modified by our surgeons (medical specialist who performs surgery, a different specialty from anaesthetist) to achieve pain relief among patients undergoing breast removal surgery. This method is called local infiltration analgesia (LIA). The pain control is achieved by having the surgeons to deliver a pain control drug surgically during the breast removal operation. LIA could be a good pain control alternative when a Pecs block could not be performed.
The investigators hope to compare the quality of pain relief provided by local infiltration analgesia delivered by surgeon and Pecs block delivered by anaesthetist under ultrasound guidance. The investigators hope to show that LIA delivered by surgeon is as effective as Pecs block in patients undergoing mastectomy with axillary dissection.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore, 529889
- Recruiting
- Changi General Hospital
-
Contact:
- Kwee Lian Woon
- Phone Number: +65 81211037
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age above 21 years old
- Able to give consent
- Body weight > 50kg
Exclusion Criteria:
- Patient's refusal and inability to give consent
- Allergy or contraindicated to local anaesthetics, paracetamol, NSAIDS or opioids
- Background history of chronic pain
- Bilateral procedures
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: PECs Block
Total local anaesthetic dose: 30ml ropivacaine 0.5% •Pecs block will be performed by anaesthetist using ultrasound guidance in plane approach: 10ml ropivacaine 0.5% will be delivered at the plane between pectoralis major and pectoralis minor, another 20ml ropivacaine 0.5% will be delivered in the plane between the pectoralis minor and serratus anterior muscles at the level of the third and fourth ribs |
Regional Anaesthesia Technique ie Pectoralis Nerve Block under ultrasound guidance
|
|
PLACEBO_COMPARATOR: Local Infiltration
LIA will be performed by surgeon during the operation.
The upper skin flap will be raised in the standard manner for mastectomy.
The lateral border of the major pectoralis muscle will then be visualised.
A volume of 10 ml ropivacaine 0.5% will be delivered between the inter-fascial planes of the pectoral muscles.
The lower skin flap will then be raised in the standard manner for mastectomy and the breast is raised off the pectoralis muscle exposing the serratus anterior muscle.
A volume of 20 ml ropivacaine 0.5% will be delivered between the muscle planes of the serratus anterior and pectoralis minor muscles.
|
LIA will be performed by surgeon during the operation.
The upper skin flap will be raised in the standard manner for mastectomy.
The lateral border of the major pectoralis muscle will then be visualised.
A volume of 10 ml ropivacaine 0.5% will be delivered between the inter-fascial planes of the pectoral muscles.
The lower skin flap will then be raised in the standard manner for mastectomy and the breast is raised off the pectoralis muscle exposing the serratus anterior muscle.
A volume of 20 ml ropivacaine 0.5% will be delivered between the muscle planes of the serratus anterior and pectoralis minor muscles.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total morphine consumption in 24 hour after surgery
Time Frame: 24 hour
|
Total morphine consumption in 24 hour after surgery
|
24 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of analgesia
Time Frame: 24 hours
|
time to first rescue analgesia after administration of block
|
24 hours
|
|
Postoperative pain score.
Time Frame: 24 hours
|
Post op pain score will be assessed using a visual analogue scale (VAS, 0-10; 0 = no pain and 10 = worst imaginable pain).
The vital signs and pain score will be recorded at 0, 0.5, 1, 2, 4, 6, 8, 12, and 24 h after surgery by the attending staff nurses blinded to the group allocation
|
24 hours
|
|
Adverse Effects
Time Frame: 24 hours
|
Any adverse effects will be recorded (such as hypotension, respiratory depression, pruritus, shivering and urinary retention)
|
24 hours
|
|
Postoperative nausea vomiting (PONV)
Time Frame: 24 hours
|
Postoperative nausea vomiting (PONV)
|
24 hours
|
|
Intraoperative analgesia
Time Frame: 24 hours
|
total usage of IV Fentanyl intraoperatively
|
24 hours
|
|
Operative time
Time Frame: 24 hrs
|
duration of surgery
|
24 hrs
|
|
Block performance time
Time Frame: 24 hours
|
time from needle insertion until needle exit from the skin
|
24 hours
|
|
Block related complications
Time Frame: 24 hours
|
pneumothorax
|
24 hours
|
|
Block related complications
Time Frame: 24 hours
|
vascular puncture
|
24 hours
|
|
Block related complications
Time Frame: 24 hours
|
local anaesthetic toxicity
|
24 hours
|
|
Post-operative complications
Time Frame: 24 hours
|
Bleeding
|
24 hours
|
|
Post-operative complications
Time Frame: 24 hours
|
Wound infection
|
24 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kwee Lian Woon, Changi General Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017/2894
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia, Local
-
University Health Network, TorontoActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMRecruitingPrediction Models for Cardiovascular and Neurocognitive Disease Risk in the General Population (CME)Anesthesia, Local | AnesthesiaFrance
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | AnesthesiaGermany
-
Grünenthal GmbHTerminatedAnalgesia | Anesthesia, Local | AnesthesiaNetherlands
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | Anesthesia | Anesthesia; Adverse EffectGermany
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMRecruiting
-
Novocol Pharmaceutical of Canada, Inc.CompletedAnesthesia, Local | Dental Anesthesia | Anesthesia, ReversalUnited States
-
Kfir SiagNot yet recruiting
-
University Health Network, TorontoCompleted
-
Hams Hamed AbdelrahmanCompleted
Clinical Trials on PECs Block
-
Assiut UniversityNot yet recruiting
-
Assiut UniversityActive, not recruiting
-
Mansoura UniversityUnknownPost Mastectomy Pain Syndrome | After Breast Surgery
-
Antalya Training and Research HospitalCompletedAnalgesia | Anesthesia | Nerve Block | Cardiac Implantable Electronic DeviceTurkey
-
University of British ColumbiaRecruitingBreast Reconstruction | Mastectomy | Nerve Block | Surgery, PlasticCanada
-
Ain Shams UniversityCompleted
-
Gangnam Severance HospitalRecruitingBreast CancerKorea, Republic of
-
Aretaieion University HospitalCompletedPain, Postoperative | Breast Cancer | Breast Neoplasms | Chronic Pain | Anesthesia | Breast Cancer Female | Pain Syndrome | Breast Pain | Breast Soft Tissue NeoplasmGreece, Cyprus
-
Suez Canal UniversityCompletedBreast Cancer | MastectomyEgypt
-
Baskent UniversityCompletedBreast NeoplasmsTurkey